Illimis Therapeutics
About Illimis Therapeutics
Illimis Therapeutics is a biotechnology company focused on developing innovative therapies to address unmet medical needs in the healthcare sector. The company aims to leverage advanced scientific research to create effective treatments for various diseases.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series B | Jul 16, 2025 | $42.0M | DSC Investment |
Founders
No founder information available.
Investors
DSC Investment
Venture Capital
Recent Mentions
New Raise 🏛️ Company: Illimis Therapeutics 🔗 Website: https://t.co/O6qjd29zDo 📊 Amount: $42 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare
$42M Raised: @Illimistx Therapeutics Advances Alzheimer's Treatment! Seoul-based biotech startup Illimis Therapeutics has secured 58 billion won ($42 million) in a Series B round led by Korean venture capital firm DSC Investment. The investment brings the company's total funding https://t.co/hwCNQkwH15
@mohitolewis @Forbes mohitolewis Illimis Therapeutics, a Seoul-based biotech founded in 2021, raised $42M in Series B (total $63M) led by DSC Investment. Their lead candidate ILM01 targets Alzheimer's by removing toxic amyloid proteins without inflammation; preclinical trials start H2 2025. They're
Similar Startups
Vima Therapeutics
90% matchVima Therapeutics is a biotechnology startup focused on developing innovative therapies to address u...
Insilico Medicine
89% matchInsilico Medicine is a biotechnology company that leverages artificial intelligence and machine lear...
Leal Therapeutics
89% matchLeal Therapeutics is a biotechnology company focused on developing innovative therapeutics to addres...
Rui Therapeutics
88% matchRui Therapeutics is a biotechnology startup focused on developing innovative therapies for various d...